New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

Ou Pengcheng; Li Fangfang; Chen Jun

首页> 外文期刊>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association >New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

【24h】

New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

机译：新的直接作用抗病毒药物可以在丙型肝炎病毒感染患者中是肝毒性，并肝硬化

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association》 |2016年第11期|共4页
作者
Ou Pengcheng; Li Fangfang; Chen Jun;
展开▼
作者单位

Cent S Univ Xiangya Hosp 2 Liver Dis Ctr Changsha Hunan Peoples R China;

Cent S Univ Xiangya Hosp 2 Liver Dis Ctr Changsha Hunan Peoples R China;

Cent S Univ Xiangya Hosp 2 Liver Dis Ctr Changsha Hunan Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis [J] . Ou Pengcheng, Li Fangfang, Chen Jun Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第11期

机译：新型直接作用抗病毒药可对丙型肝炎病毒感染和代偿性肝硬化患者产生肝毒性
2. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis Reply [J] . Ho Samuel B. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第11期

机译：新的直接抗病毒剂可以在丙型肝炎病毒感染患者中是肝毒性和失代偿的肝硬化答复
3. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis [J] . Ou Pengcheng, Li Fangfang, Chen Jun Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第11期

机译：新的直接作用抗病毒药物可以在丙型肝炎病毒感染患者中是肝毒性，并肝硬化
4. MALDI-TOF MS for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy [C] . Magda Rybicka, Piotr Stalke, Tomasz Smiatacz, International Mass Spectrometry Conference . 2014

机译：MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection [O] . Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, 2017

机译：接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
7. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis [O] . Raoel Maan, Marjolein van Tilborg, Katja Deterding, 2016

机译：直效抗病毒剂治疗慢性丙型肝炎病毒感染患者的安全性和有效性及肝硬化
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

著录项

相似文献

相关主题

期刊订阅